130 related articles for article (PubMed ID: 2011211)
1. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
[TBL] [Abstract][Full Text] [Related]
2. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
Kubasova T; Bank J; Köteles GJ; Horváth M
Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
[TBL] [Abstract][Full Text] [Related]
4. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
[TBL] [Abstract][Full Text] [Related]
5. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
7. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
8. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
9. LAI reactivity in rats immunized with tumor cells.
Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
[TBL] [Abstract][Full Text] [Related]
10. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
11. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
Kalafut F; Hung PM; Novotná L; Grófová M
Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
[TBL] [Abstract][Full Text] [Related]
12. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
13. [Leukocyte adherence inhibition test in tumor patients].
Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
[TBL] [Abstract][Full Text] [Related]
14. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
Kalafut F; Klobusická M; Novotná L
Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
[TBL] [Abstract][Full Text] [Related]
16. Blocking factor in sera of MC1 and B77 tumor bearing rats detected by LAI assay.
Pham Manh Hung ; Kalafut F; Novotná L
Neoplasma; 1979; 26(3):291-8. PubMed ID: 231213
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
18. Comparison of LAI reactivity in B 77 tumor bearing rats between, before and after surgical removal of tumors.
Pham Manh Hung ; Kalafut F; Novotná L
Neoplasma; 1980; 27(4):367-71. PubMed ID: 7005698
[TBL] [Abstract][Full Text] [Related]
19. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
[TBL] [Abstract][Full Text] [Related]
20. [Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay].
Xu WM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):116-8. PubMed ID: 1377621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
